Abstract:Background: A significant burden of atherosclerotic disease is driven by inflammation. Recently, microRNAs (miRNAs) have emerged as important factors driving and protecting from atherosclerosis. miR-223 regulates cholesterol metabolism and inflammation via targeting both cholesterol biosynthesis pathway and NFkB signaling pathways; however, its role in atherosclerosis has not been investigated. We hypothesize that miR-223 globally regulates core inflammatory pathways in macrophages in response to inflammatory and atherogenic stimuli thus limiting the progression of atherosclerosis. Methods and results: Loss of miR-223 in macrophages decreases Abca1 gene and protein expression as well as cholesterol efflux to apoA1 (Apolipoprotein A1) and enhances proinflammatory gene expression. In contrast, overexpression of miR-223 promotes the efflux of cholesterol and macrophage polarization toward an anti-inflammatory phenotype. These beneficial effects of miR-223 are dependent on its target gene, the transcription factor Sp3. Consistent with the antiatherogenic effects of miR-223 in vitro, mice receiving miR223-/- bone marrow exhibit increased plaque size, lipid content, and circulating inflammatory cytokines (ie, IL-1β). Deficiency of miR-223 in bone marrow-derived cells also results in an increase in circulating pro-atherogenic cells (total monocytes and neutrophils) compared with control mice. Furthermore, the expression of miR-223 target gene (Sp3) and pro-inflammatory marker (Il-6) are enhanced whereas the expression of Abca1 and anti-inflammatory marker (Retnla) are reduced in aortic arches from mice lacking miR-223 in bone marrow-derived cells. In mice fed a high-cholesterol diet and in humans with unstable carotid atherosclerosis, the expression of miR-223 is increased. To further understand the molecular mechanisms underlying the effect of miR-223 on atherosclerosis in vivo, we characterized global RNA translation profile of macrophages isolated from mice receiving wild-type or miR223-/- bone marrow. Using ribosome profiling, we reveal a notable upregulation of inflammatory signaling and lipid metabolism at the translation level but less significant at the transcription level. Analysis of upregulated genes at the translation level reveal an enrichment of miR-223-binding sites, confirming that miR-223 exerts significant changes in target genes in atherogenic macrophages via altering their translation. Conclusions: Our study demonstrates that miR-223 can protect against atherosclerosis by acting as a global regulator of RNA translation of cholesterol efflux and inflammation pathways.

An Endocrine Genetic Signal Between Blood Cells and Vascular Smooth Muscle Cells

MicroRNA-125a-mediated Regulation of the Mevalonate Signaling Pathway Contributes to High Glucose-Induced Proliferation and Migration of Vascular Smooth Muscle Cells

Integrative Analysis of Key Microrna-Mrna Complexes and Pathways in Aortic Aneurysm

Association Between Elevated Plasma Microrna-223 Content and Severity of Coronary Heart Disease

miR-223 Exerts Translational Control of Proatherogenic Genes in Macrophages

Abstract P640: Endogenous Micrornas in Human Microvascular Endothelial Cells Regulate Mrnas Encoded by Hypertension-Related Genes and Are Functionally Important

Abstract 162: MicroRNAs Mediate the Hemodynamic Regulation of Endothelium-to-Smooth Muscle Signaling

Flow-Regulation Of Vascular Smooth Muscle Cell Proliferation: Roles Of Endothelial Cell-Secreted Microrna-126

Regulation of Vascular Smooth Muscle Cell Turnover by Endothelial Cell–Secreted MicroRNA-126

MiR-223-3p in Cardiovascular Diseases: A Biomarker and Potential Therapeutic Target

MicroRNA-223 Inhibits Tissue Factor Expression in Vascular Endothelial Cells

Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration

Secreted Monocytic Mir-150 Enhances Targeted Endothelial Cell Migration.

Regulation of Vascular Smooth Muscle Cell Turnover by Endothelial Cell-Secreted Microrna-126: Role of Shear Stress

Bone Marrow-Derived MicroRNA-223 Works as an Endocrine Genetic Signal in Vascular Endothelial Cells and Participates in Vascular Injury From Kawasaki Disease

MicroRNA-137 and MicroRNA-195*Inhibit Vasculogenesis in Brain Arteriovenous Malformations

MicroRNA-223-3p Inhibits the Angiogenesis of Ischemic Cardiac Microvascular Endothelial Cells via Affecting RPS6KB1/hif-1a Signal Pathway

Abstract 15695: Hematopoietic Deficiency of miR-223 Attenuates Thrombosis in Response to Photochemical Injury in Mice

Inflammation Induced-Endothelial Cells Release Angiogenesis Associated-Micrornas into Circulation by Microparticles

Microvesicle-mediated Transfer of MicroRNA-150 from Monocytes to Endothelial Cells Promotes Angiogenesis

Platelet-Secreted MicroRNA-223 Promotes Endothelial Cell Apoptosis Induced by Advanced Glycation End Products Via Targeting the Insulin-like Growth Factor 1 Receptor